Testosterone undecanoate (TU)

Product Overview

Alternative Name: TU, Aveed

Development Status: Inactive

Target: Male

Mode: Hormonal

Delivery Type: Injectable

Duration Type: Short-acting

Description: Testosterone undecanoate (TU) is manufactured by Bayer Health Care and the injectable formulation was recently approved by the FDA (Aveed) to be marketed by Endo Pharmaceuticals for treatment of hypogonadism. It is not approved for use as a contraceptive agent.

Updated date: May 30, 2018

Vertical Tabs

Status

Project Phase: Late Development

Project Stage: Phase III

Status Details:
  • A phase III trial was completed in China in 2008 by the National Research Institute for Family Planning.
  • In the Chinese study, TU was evaluated as a stand-alone contraceptive, but it is unlikely that further development will happen with it as as a single API product, but would rather be developed with a progestin added.

Download Product Report